Jasper Bos is the current Director at Precirix. Jasper has also previously served as Senior Vice President & Managing Director at M Ventures, Member of the Board of Directors at Metabomed Ltd., Board Member at ObsEva SA, Chairman Of The Board Of Directors at Calypso Biotech SA, Board Member at Prexton Therapeutics SA, Board Member at Neviah Genomics, and Member of the Board of Directors at Galecto, Inc. Prior to their current role, Jasper was the Senior Director MS Ventures at Merck Serono from March 2009 to January 2019.
Jasper Bos earned their PhD in pharmacy from the University of Groningen. Jasper also has a degree in corporate finance from the Amsterdam Institute of Finance. Jasper earned their MSc in pharmacy from the University of Groningen.
This person is not in the org chart